For press inquiries click here to contact us.
Kinnate Biopharma (Alumni)
Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share
Xaira Therapeutics
Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D
Alumis, Inc. (Alumni)
Alumis closes $259M series C in year’s largest private biotech fundraise yet
Thyme Care
This Startup Just Raised $60 Million To Help Cancer Patients Navigate Their Care
CG Oncology
CG Oncology reels in $105M crossover for potential late 2024 bladder cancer drug filing
Everly Health
Scoop: Everly partnership to offer home cancer tests to health plan
Remix Therapeutics
Is there room for a new way to drug RNA? ARCH, Foresite join Atlas, The Column Group for $81M bet
Tasso, Inc.
Health Innovation of the Year: 5 finalists at the GeekWire Awards span fields and approaches
SomaLogic (Alumni)
SomaLogic Targeting Cardiovascular Risk Panel for Use as Surrogate Endpoint in Drug Development
Please see important disclaimers in the Terms section.
